price
RE
NASDAQ · REPL
Replimune Group, Inc.
Healthcare · Biotechnology
$14.05
Up+$0.72 (+5.12%)
Updated Aug 21, 2026, 11:22 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 774.6M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $15.71
- Volume
- 4.3M
- Avg. volume
- 5.08M
Price performance
REPL price history
1M range · 20 trading sessions · Daily adjusted prices
REPL closed at $14.05 after 20 trading sessions, up 34.32% for the selected period.
- Last close
- $14.05
- Period change
- +34.32%
- Period low
- $5.35
- Period high
- $15.58
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | $14.55 | $14.765 | $13.92 | $14.05 | 4.3M |
| Aug 19, 2026 | $15.17 | $15.64 | $14.73 | $14.81 | 3.44M |
| Aug 18, 2026 | $14.60 | $15.615 | $14.50 | $15.58 | 2.25M |
| Aug 17, 2026 | $14.65 | $14.69 | $14.05 | $14.63 | 3.74M |
| Aug 14, 2026 | $15.19 | $15.39 | $14.685 | $14.97 | 2.4M |
| Aug 13, 2026 | $15.00 | $15.705 | $14.98 | $15.19 | 3.22M |
| Aug 12, 2026 | $13.62 | $15.68 | $13.62 | $15.24 | 8.27M |
| Aug 11, 2026 | $13.755 | $14.14 | $13.20 | $13.65 | 4.77M |
| Aug 10, 2026 | $12.64 | $14.12 | $12.27 | $13.67 | 8.86M |
| Aug 7, 2026 | $13.00 | $13.40 | $11.42 | $12.06 | 8.91M |
| Aug 6, 2026 | $11.78 | $13.90 | $11.58 | $12.86 | 7.28M |
| Aug 5, 2026 | $11.96 | $12.35 | $11.50 | $11.83 | 2.86M |
| Aug 4, 2026 | $12.67 | $13.86 | $11.50 | $11.92 | 6.09M |
| Aug 3, 2026 | $10.995 | $12.60 | $10.13 | $11.91 | 11.77M |
| Jul 31, 2026 | $11.379 | $12.50 | $9.43 | $11.20 | 33.63M |
| Jul 29, 2026 | $5.25 | $5.57 | $4.7648 | $5.41 | 14.3M |
| Jul 28, 2026 | $6.61 | $6.62 | $5.135 | $5.35 | 24.02M |
| Jul 27, 2026 | $8.685 | $9.15 | $7.37 | $8.63 | 8.46M |
| Jul 24, 2026 | $10.30 | $10.375 | $9.65 | $9.70 | 3.27M |
| Jul 23, 2026 | $10.71 | $10.98 | $10.27 | $10.46 | 3.79M |
Latest REPL news
The latest Smart Investors Daily articles mentioning REPL.
Stock researchCompany · Earnings
Loading stock research…